To understand the genetic basis underlying MHG-DLBCL and its aggressive clinical behaviour, we compared the mutation profile among MHG, GCB and ABC subtype, and also between MHG and GCB within MYC/BCL2 double-hit groups (Fig. 4). Here, MYC is linked to diffuse large B-cell lymphoma.